Cytochrome P450 3A Inhibitor [EPC]

Cytochrome P450 3A Inhibitor [EPC] was reported 60444 times

Drugs of the Cytochrome P450 3A Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 116 0.8992
1 AIDS ENCEPHALOPATHY 43 0.7414
2 ULTRASOUND ANTENATAL SCREEN 59 0.6146
3 CLOACAL EXSTROPHY 32 0.5424
4 BLOOD HIV RNA 28 0.5385
5 TOOTH INJURY 1999 0.4600
6 BONE DEMINERALISATION 482 0.4551
7 BLADDER AGENESIS 33 0.4459
8 AIDS DEMENTIA COMPLEX 27 0.4426
9 SKELETAL INJURY 4202 0.4059
10 ALPHA 1 FOETOPROTEIN ABNORMAL 40 0.4000
11 SUPERNUMERARY NIPPLE 32 0.3902
12 TOTAL LUNG CAPACITY INCREASED 103 0.3787
13 CARDIAC MALPOSITION 28 0.3684
14 GASTROINTESTINAL DISORDER CONGENITAL 35 0.3302
15 CONGENITAL NAEVUS 46 0.3239
16 LIPODYSTROPHY ACQUIRED 653 0.3073
17 MITOCHONDRIAL TOXICITY 248 0.3021
18 ERGOT POISONING 37 0.2960
19 HYPERCORTICOIDISM 31 0.2925
20 CSF HIV ESCAPE SYNDROME 40 0.2899
21 BONE LOSS 4304 0.2860
22 BONE DENSITY DECREASED 8565 0.2731
23 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 29 0.2613
24 IMMUNE RECONSTITUTION SYNDROME 333 0.2579
25 CUSHING'S SYNDROME 172 0.2475
26 GENITALIA EXTERNAL AMBIGUOUS 42 0.2428
27 MECONIUM STAIN 37 0.2403
28 CD4 LYMPHOCYTES ABNORMAL 50 0.2381
29 MULTIPLE FRACTURES 3909 0.2377
30 HEMIVERTEBRA 40 0.2367
31 CAUDAL REGRESSION SYNDROME 35 0.2244
32 ULTRASOUND ANTENATAL SCREEN ABNORMAL 49 0.2227
33 TOOTH LOSS 4351 0.2097
34 FANCONI SYNDROME ACQUIRED 357 0.2032
35 TRISOMY 18 77 0.2021
36 ACOUSTIC STIMULATION TESTS ABNORMAL 31 0.1987
37 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
38 CONGENITAL GENITAL MALFORMATION 30 0.1875
39 VIROLOGIC FAILURE 964 0.1791
40 BLOOD HIV RNA INCREASED 311 0.1713
41 KAPOSI'S SARCOMA 86 0.1713
42 ACQUIRED IMMUNODEFICIENCY SYNDROME 85 0.1638
43 CD4 LYMPHOCYTES DECREASED 344 0.1605
44 RENAL INJURY 4760 0.1601
45 VENTRICULAR HYPOPLASIA 40 0.1600
46 OSTEOPENIA 2410 0.1586
47 FAT REDISTRIBUTION 35 0.1509
48 ADRENAL SUPPRESSION 122 0.1447
49 ANHEDONIA 3791 0.1441
50 BONE DENSITY ABNORMAL 526 0.1406
51 TETHERED CORD SYNDROME 31 0.1403
52 TRISOMY 21 176 0.1397
53 OSTEONECROSIS 4580 0.1393
54 MITOCHONDRIAL CYTOPATHY 60 0.1364
55 EXOMPHALOS 73 0.1359
56 PROTEIN TOTAL ABNORMAL 175 0.1344
57 LIPOHYPERTROPHY 83 0.1334
58 CONGENITAL CHOROID PLEXUS CYST 39 0.1279
59 SYPHILIS 91 0.1252
60 POLYDACTYLY 145 0.1250
61 LOW SET EARS 51 0.1241
62 UMBILICAL CORD ABNORMALITY 63 0.1195
63 VIRAL LOAD INCREASED 463 0.1191
64 SPINE MALFORMATION 41 0.1182
65 OESOPHAGEAL ATRESIA 73 0.1168
66 DEGENERATIVE BONE DISEASE 51 0.1151
67 RENAL TUBULAR DYSFUNCTION 64 0.1133
68 GENOTYPE DRUG RESISTANCE TEST POSITIVE 116 0.1128
69 OSTEOMALACIA 170 0.1100
70 FANCONI SYNDROME 154 0.1088
71 CHOLESTASIS OF PREGNANCY 50 0.1087
72 RENAL TUBULAR DISORDER 301 0.1069
73 VIRAL MUTATION IDENTIFIED 387 0.1050
74 BLOOD CORTISOL DECREASED 67 0.1047
75 OSTEOPOROSIS 4136 0.1004
76 ATRIOVENTRICULAR SEPTAL DEFECT 47 0.1000
77 LIPOATROPHY 95 0.0998
78 ECONOMIC PROBLEM 1501 0.0989
79 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 35 0.0975
80 CONGENITAL HYDROCEPHALUS 49 0.0966
81 MENINGOMYELOCELE 57 0.0950
82 NEURAL TUBE DEFECT 69 0.0949
83 NEURODEVELOPMENTAL DISORDER 64 0.0947
84 HYDROPS FOETALIS 57 0.0930
85 TERATOGENICITY 28 0.0927
86 ANAL ATRESIA 49 0.0918
87 RENAL COLIC 204 0.0901
88 PSYCHIATRIC DECOMPENSATION 176 0.0900
89 STILLBIRTH 431 0.0891
90 BLIGHTED OVUM 35 0.0891
91 SINGLE UMBILICAL ARTERY 32 0.0867
92 CONGENITAL HYDRONEPHROSIS 62 0.0867
93 RENAL DYSPLASIA 33 0.0853
94 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 420 0.0842
95 GASTROSCHISIS 40 0.0840
96 GLYCOSURIA 113 0.0836
97 SKULL MALFORMATION 53 0.0824
98 GLOMERULAR FILTRATION RATE ABNORMAL 114 0.0805
99 CENTRAL OBESITY 55 0.0744
100 ANENCEPHALY 42 0.0743
101 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 80 0.0739
102 TEETH BRITTLE 76 0.0726
103 HIV INFECTION 217 0.0719
104 CHRONIC KIDNEY DISEASE 5468 0.0719
105 PLACENTA PRAEVIA 56 0.0712
106 CEREBRAL VENTRICLE DILATATION 82 0.0711
107 VITAMIN D DEFICIENCY 689 0.0706
108 CONGENITAL FOOT MALFORMATION 32 0.0705
109 SPINA BIFIDA 144 0.0691
110 NEPHROPATHY 644 0.0689
111 BLOOD BILIRUBIN UNCONJUGATED INCREASED 50 0.0689
112 ANAEMIA NEONATAL 32 0.0664
113 CEREBRAL TOXOPLASMOSIS 62 0.0664
114 CONGENITAL MUSCULOSKELETAL ANOMALY 29 0.0658
115 POLYHYDRAMNIOS 66 0.0646
116 PYELOCALIECTASIS 60 0.0626
117 PREMATURE RUPTURE OF MEMBRANES 151 0.0626
118 SECONDARY ADRENOCORTICAL INSUFFICIENCY 94 0.0622
119 INTRA-UTERINE DEATH 97 0.0604
120 CALCULUS URINARY 89 0.0578
121 PSYCHOMOTOR SKILLS IMPAIRED 151 0.0576
122 ANOGENITAL WARTS 50 0.0561
123 PLACENTAL INSUFFICIENCY 45 0.0560
124 PLACENTAL DISORDER 51 0.0539
125 HYPERTRIGLYCERIDAEMIA 309 0.0527
126 JAUNDICE CHOLESTATIC 185 0.0523
127 CYTOMEGALOVIRUS CHORIORETINITIS 100 0.0512
128 ABORTION INDUCED 478 0.0507
129 HYPOMANIA 184 0.0500
130 HIV TEST POSITIVE 33 0.0499
131 NODULAR REGENERATIVE HYPERPLASIA 32 0.0498
132 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 161 0.0487
133 FOETAL GROWTH RETARDATION 38 0.0485
134 CYTOLYTIC HEPATITIS 160 0.0481
135 LIVE BIRTH 395 0.0472
136 LIMB MALFORMATION 37 0.0469
137 DEPRESSION SUICIDAL 162 0.0468
138 CLEFT LIP AND PALATE 52 0.0465
139 DYSLIPIDAEMIA 234 0.0460
140 HYPERBILIRUBINAEMIA 474 0.0457
141 PATHOGEN RESISTANCE 417 0.0457
142 RENAL APLASIA 32 0.0455
143 HODGKIN'S DISEASE 33 0.0455
144 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 48 0.0452
145 TWIN PREGNANCY 38 0.0452
146 MYCOBACTERIUM AVIUM COMPLEX INFECTION 121 0.0450
147 DEPRESSIVE SYMPTOM 158 0.0448
148 PORTAL HYPERTENSION 138 0.0447
149 CUSHINGOID 143 0.0445
150 OPHTHALMOPLEGIA 70 0.0443
151 ANAL CANCER 43 0.0443
152 TOXOPLASMOSIS 47 0.0435
153 PULMONARY HYPOPLASIA 34 0.0431
154 RENAL TUBULAR ACIDOSIS 94 0.0430
155 HYPERLACTACIDAEMIA 115 0.0428
156 VIRAEMIA 59 0.0426
157 FOETAL GROWTH RESTRICTION 255 0.0419
158 OSTEOPOROTIC FRACTURE 80 0.0418
159 PREMATURE LABOUR 231 0.0408
160 FAT TISSUE INCREASED 59 0.0407
161 LOW BIRTH WEIGHT BABY 318 0.0400
162 CRYPTORCHISM 44 0.0392
163 FOETAL EXPOSURE DURING PREGNANCY 3141 0.0386
164 PNEUMOCYSTIS JIROVECI PNEUMONIA 86 0.0386
165 FOETAL DEATH 200 0.0385
166 COARCTATION OF THE AORTA 37 0.0383
167 MICROCEPHALY 49 0.0382
168 TEARFULNESS 163 0.0379
169 FOETAL HEART RATE ABNORMAL 35 0.0378
170 RENAL FAILURE 4954 0.0373
171 PROTEIN TOTAL INCREASED 99 0.0371
172 PREMATURE BABY 1106 0.0367
173 DRUG EXPOSURE DURING PREGNANCY 1241 0.0364
174 MENINGITIS CRYPTOCOCCAL 63 0.0360
175 HAND FRACTURE 255 0.0360
176 RETINAL TOXICITY 37 0.0359
177 CHLAMYDIAL INFECTION 27 0.0357
178 SKIN STRIAE 53 0.0356
179 CYTOGENETIC ABNORMALITY 40 0.0354
180 EMOTIONAL DISTRESS 4291 0.0354
181 PRURIGO 32 0.0347
182 GLOMERULAR FILTRATION RATE INCREASED 28 0.0339
183 FRACTURE 642 0.0339
184 OESOPHAGEAL CANDIDIASIS 134 0.0336
185 VENTRICULAR SEPTAL DEFECT 189 0.0330
186 DRUG RESISTANCE 839 0.0326
187 NEPHRITIS INTERSTITIAL 41 0.0324
188 HYDROCELE 34 0.0319
189 MULTIPLE-DRUG RESISTANCE 98 0.0316
190 ABORTION SPONTANEOUS 1261 0.0314
191 SMALL FOR DATES BABY 156 0.0314
192 PREMATURE SEPARATION OF PLACENTA 48 0.0312
193 FOLATE DEFICIENCY 36 0.0311
194 CAESAREAN SECTION 362 0.0311
195 DEATH NEONATAL 43 0.0309
196 FOETAL MALFORMATION 33 0.0304
197 LONG QT SYNDROME 72 0.0300
198 END STAGE RENAL DISEASE 545 0.0299
199 BLOOD AMYLASE INCREASED 51 0.0298
200 TOOTH FRACTURE 328 0.0297
201 HEART DISEASE CONGENITAL 105 0.0297
202 PREMATURE DELIVERY 469 0.0294
203 FOETAL DISTRESS SYNDROME 62 0.0292
204 BLOOD LACTIC ACID INCREASED 153 0.0290
205 DRUG INTERACTION 4451 0.0280
206 OCULAR ICTERUS 120 0.0277
207 PSYCHOMOTOR RETARDATION 77 0.0274
208 FOOT FRACTURE 519 0.0273
209 DYSMORPHISM 64 0.0271
210 NORMAL NEWBORN 146 0.0268
211 CONGENITAL ANOMALY 205 0.0265
212 CARDIAC MURMUR 229 0.0264
213 PROTEINURIA 500 0.0263
214 GENE MUTATION 52 0.0262
215 LIPIDS INCREASED 53 0.0262
216 ATYPICAL MYCOBACTERIAL INFECTION 37 0.0261
217 MYCOBACTERIAL INFECTION 45 0.0261
218 HEPATOSPLENOMEGALY 67 0.0261
219 MATERNAL DRUGS AFFECTING FOETUS 196 0.0255
220 RHINITIS ALLERGIC 112 0.0251
221 NEONATAL DISORDER 39 0.0246
222 HYPOPHOSPHATAEMIA 182 0.0246
223 HYPOSPADIAS 51 0.0245
224 BONE MARROW TOXICITY 29 0.0245
225 BLOOD CREATININE INCREASED 1599 0.0245
226 VARICES OESOPHAGEAL 74 0.0244
227 ECTOPIC PREGNANCY 75 0.0244
228 PATENT DUCTUS ARTERIOSUS 96 0.0242
229 RADIUS FRACTURE 58 0.0241
230 SARCOIDOSIS 112 0.0236
231 CACHEXIA 121 0.0235
232 PRE-ECLAMPSIA 110 0.0231
233 EYELID PTOSIS 234 0.0230
234 WHITE MATTER LESION 29 0.0229
235 NON-HODGKIN'S LYMPHOMA 30 0.0229
236 FIBULA FRACTURE 66 0.0229
237 TALIPES 71 0.0228
238 JAW FRACTURE 49 0.0227
239 RENAL TUBULAR NECROSIS 222 0.0226
240 BLOOD BILIRUBIN INCREASED 608 0.0225
241 ADRENAL INSUFFICIENCY 268 0.0221
242 GLOMERULAR FILTRATION RATE DECREASED 266 0.0216
243 OPPORTUNISTIC INFECTION 40 0.0216
244 EXPOSURE DURING PREGNANCY 1333 0.0214
245 NASAL POLYPS 104 0.0211
246 HYDROCEPHALUS 115 0.0211
247 ANAEMIA MACROCYTIC 45 0.0211
248 HEPATITIS CHOLESTATIC 127 0.0211
249 SCHIZOPHRENIA 255 0.0210
250 GENITAL HERPES 32 0.0209
251 CYSTITIS NONINFECTIVE 28 0.0208
252 ANKLE FRACTURE 322 0.0208
253 NEPHROPATHY TOXIC 233 0.0207
254 OLIGOHYDRAMNIOS 69 0.0207
255 TIBIA FRACTURE 97 0.0207
256 HEPATOCELLULAR INJURY 293 0.0206
257 RENAL IMPAIRMENT 1732 0.0206
258 WRIST FRACTURE 246 0.0205
259 GESTATIONAL DIABETES 96 0.0201
260 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 166 0.0201
261 BONE DISORDER 364 0.0200
262 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 64 0.0197
263 VOLVULUS 46 0.0194
264 HEPATITIS B 114 0.0189
265 HEPATOTOXICITY 417 0.0187
266 NEONATAL RESPIRATORY DISTRESS SYNDROME 66 0.0186
267 BLOOD PHOSPHORUS DECREASED 68 0.0186
268 INTERVERTEBRAL DISC DEGENERATION 169 0.0182
269 HEPATITIS C 215 0.0178
270 PULMONARY TUBERCULOSIS 76 0.0178
271 CELL DEATH 35 0.0176
272 JAUNDICE 473 0.0176
273 HYPERPARATHYROIDISM SECONDARY 44 0.0175
274 MATERNAL EXPOSURE DURING PREGNANCY 1544 0.0173
275 QUALITY OF LIFE DECREASED 229 0.0171
276 CLAVICLE FRACTURE 65 0.0170
277 PREGNANCY 339 0.0169
278 DECREASED ACTIVITY 182 0.0169
279 KIDNEY FIBROSIS 29 0.0167
280 CRYPTOCOCCOSIS 27 0.0166
281 HYPERURICAEMIA 68 0.0165
282 HYPERLIPIDAEMIA 197 0.0165
283 HEPATOMEGALY 162 0.0165
284 RENAL FAILURE ACUTE 693 0.0163
285 BRONCHIECTASIS 109 0.0162
286 DRUG LEVEL INCREASED 266 0.0161
287 ATRIAL SEPTAL DEFECT 133 0.0159
288 PROTEIN URINE PRESENT 79 0.0158
289 BLOOD BICARBONATE DECREASED 30 0.0158
290 BLOOD TRIGLYCERIDES INCREASED 280 0.0158
291 MECHANICAL VENTILATION 30 0.0158
292 PORTAL VEIN THROMBOSIS 51 0.0158
293 VENTRICULAR HYPERTROPHY 39 0.0155
294 RIB FRACTURE 319 0.0155
295 SPINAL COMPRESSION FRACTURE 128 0.0155
296 ANXIETY 4374 0.0154
297 UNDERWEIGHT 30 0.0152
298 NEPHROLITHIASIS 690 0.0150
299 ENDOTRACHEAL INTUBATION 42 0.0150
300 BILIRUBIN CONJUGATED INCREASED 35 0.0150
301 HUMERUS FRACTURE 72 0.0149
302 PATHOLOGICAL FRACTURE 75 0.0148
303 OESOPHAGEAL VARICES HAEMORRHAGE 32 0.0147
304 PATELLA FRACTURE 34 0.0146
305 PSYCHOTIC DISORDER 426 0.0144
306 BLOOD CREATINE INCREASED 63 0.0142
307 HYDRONEPHROSIS 104 0.0139
308 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 667 0.0139
309 ACUTE KIDNEY INJURY 2072 0.0135
310 ALANINE AMINOTRANSFERASE ABNORMAL 28 0.0133
311 HYPERCHOLESTEROLAEMIA 127 0.0131
312 CHOLESTASIS 251 0.0131
313 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 115 0.0130
314 INTRAVENTRICULAR HAEMORRHAGE 32 0.0129
315 SPINAL STENOSIS 53 0.0128
316 CEREBELLAR SYNDROME 28 0.0128
317 FACIAL BONES FRACTURE 46 0.0128
318 SPINAL OSTEOARTHRITIS 111 0.0126
319 HEPATOCELLULAR DAMAGE 28 0.0124
320 POLYDIPSIA 49 0.0124
321 CHOLELITHIASIS 402 0.0122
322 GASTROINTESTINAL TUBE INSERTION 30 0.0120
323 HEPATITIS FULMINANT 35 0.0118
324 TREATMENT NONCOMPLIANCE 643 0.0117
325 TRANSAMINASES INCREASED 259 0.0116
326 DENTAL CARIES 128 0.0116
327 FEMORAL NECK FRACTURE 59 0.0115
328 HYPERTRANSAMINASAEMIA 80 0.0115
329 GAMMA-GLUTAMYLTRANSFERASE INCREASED 254 0.0114
330 RENAL CYST 91 0.0114
331 HIP ARTHROPLASTY 175 0.0114
332 ORAL CANDIDIASIS 150 0.0114
333 FIBROSIS 35 0.0114
334 PARANOIA 196 0.0114
335 MIXED LIVER INJURY 34 0.0113
336 HEPATITIS 288 0.0112
337 ENCEPHALITIS 77 0.0111
338 LACTIC ACIDOSIS 347 0.0107
339 BRAIN HERNIATION 32 0.0107
340 HEPATITIS B REACTIVATION 34 0.0107
341 DRUG LEVEL ABOVE THERAPEUTIC 49 0.0107
342 ASPARTATE AMINOTRANSFERASE INCREASED 566 0.0106
343 BENIGN PROSTATIC HYPERPLASIA 55 0.0106
344 NEPHROGENIC ANAEMIA 49 0.0106
345 LIPASE INCREASED 80 0.0104
346 BACTERIAL SEPSIS 34 0.0104
347 CONGESTIVE CARDIOMYOPATHY 43 0.0103
348 SPLENOMEGALY 120 0.0102
349 BLOOD ALKALINE PHOSPHATASE INCREASED 254 0.0102
350 CANDIDIASIS 41 0.0102
351 HEPATIC CIRRHOSIS 191 0.0102
352 ATRIOVENTRICULAR BLOCK FIRST DEGREE 44 0.0101
353 BLOOD CREATININE ABNORMAL 35 0.0101
354 LUNG NEOPLASM 43 0.0101
355 BLOOD CREATINE PHOSPHOKINASE INCREASED 288 0.0100
356 HEPATIC ENCEPHALOPATHY 93 0.0100
357 RASH MACULO-PAPULAR 221 0.0099
358 ALANINE AMINOTRANSFERASE INCREASED 609 0.0099
359 TOXIC SKIN ERUPTION 99 0.0098
360 HEPATIC NECROSIS 37 0.0098
361 BRONCHOPNEUMONIA 33 0.0096
362 OESOPHAGEAL ULCER 37 0.0096
363 DEPRESSION 2178 0.0096
364 EXERCISE TOLERANCE DECREASED 55 0.0095
365 ANOREXIA 123 0.0095
366 METABOLIC ACIDOSIS 304 0.0095
367 RENAL TRANSPLANT 34 0.0094
368 DERMATITIS EXFOLIATIVE 47 0.0094
369 PYELONEPHRITIS 81 0.0093
370 COMPRESSION FRACTURE 50 0.0093
371 HEPATIC FAILURE 279 0.0092
372 EOSINOPHILIA 162 0.0092
373 ACIDOSIS 70 0.0092
374 RENAL FAILURE CHRONIC 70 0.0091
375 RHABDOMYOLYSIS 378 0.0091
376 PNEUMOCYSTIS JIROVECII PNEUMONIA 91 0.0091
377 RENAL PAIN 96 0.0090
378 HAEMOLYTIC ANAEMIA 81 0.0090
379 CREATININE RENAL CLEARANCE DECREASED 36 0.0090
380 UPPER LIMB FRACTURE 178 0.0089
381 OSTEOARTHRITIS 378 0.0089
382 HEPATIC CYTOLYSIS 113 0.0089
383 NYSTAGMUS 47 0.0088
384 LOWER LIMB FRACTURE 170 0.0088
385 HEPATITIS ACUTE 57 0.0088
386 NEPHROTIC SYNDROME 60 0.0087
387 SPINAL FRACTURE 175 0.0087
388 POTENTIATING DRUG INTERACTION 29 0.0086
389 DIPLOPIA 224 0.0086
390 CORONARY ARTERY STENOSIS 43 0.0085
391 ODYNOPHAGIA 51 0.0085
392 GLUCOSE TOLERANCE IMPAIRED 50 0.0084
393 HEPATIC FIBROSIS 29 0.0084
394 MYOPATHY 72 0.0083
395 LUMBAR VERTEBRAL FRACTURE 38 0.0083
396 ANURIA 71 0.0082
397 DRUG TOXICITY 109 0.0080
398 HEPATIC STEATOSIS 149 0.0080
399 HIP FRACTURE 254 0.0079
400 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 30 0.0078
401 APLASIA PURE RED CELL 27 0.0078
402 ILEUS PARALYTIC 35 0.0078
403 POLYURIA 64 0.0078
404 CEREBRAL ISCHAEMIA 40 0.0078
405 PANCREATITIS ACUTE 174 0.0077
406 PANCYTOPENIA 432 0.0077
407 LYMPHOMA 119 0.0077
408 MULTI-ORGAN FAILURE 133 0.0077
409 PAIN 4694 0.0076
410 ATRIOVENTRICULAR BLOCK COMPLETE 51 0.0076
411 STRESS FRACTURE 41 0.0076
412 ASCITES 223 0.0076
413 DRUG LEVEL DECREASED 76 0.0075
414 BLOOD LACTATE DEHYDROGENASE INCREASED 117 0.0074
415 TUBULOINTERSTITIAL NEPHRITIS 137 0.0073
416 HAEMODIALYSIS 61 0.0073
417 MAJOR DEPRESSION 53 0.0072
418 MYOSITIS 65 0.0072
419 STAPHYLOCOCCAL SEPSIS 35 0.0071
420 RENAL DISORDER 325 0.0070
421 ANGINA UNSTABLE 45 0.0069
422 MALABSORPTION 36 0.0069
423 LIVER FUNCTION TEST ABNORMAL 200 0.0069
424 ACUTE MYOCARDIAL INFARCTION 202 0.0068
425 LOW DENSITY LIPOPROTEIN INCREASED 53 0.0068
426 ABDOMINAL HERNIA 31 0.0068
427 ANAEMIA 1289 0.0068
428 FAILURE TO THRIVE 35 0.0067
429 LIVER DISORDER 297 0.0067
430 GASTROINTESTINAL TOXICITY 32 0.0067
431 HERPES SIMPLEX 43 0.0066
432 ACUTE HEPATIC FAILURE 90 0.0066
433 HEPATIC ENZYME INCREASED 445 0.0065
434 HYPOTONIA 65 0.0065
435 LYMPHADENOPATHY 226 0.0064
436 HAEMOLYSIS 49 0.0063
437 CYTOMEGALOVIRUS INFECTION 105 0.0063
438 BUNDLE BRANCH BLOCK RIGHT 29 0.0063
439 ELECTROCARDIOGRAM QT PROLONGED 224 0.0062
440 PANCREATITIS 328 0.0062
441 RALES 36 0.0062
442 DYSSTASIA 181 0.0062
443 HYPOKALAEMIA 283 0.0061
444 NEUROLOGICAL SYMPTOM 35 0.0061
445 ACUTE RESPIRATORY DISTRESS SYNDROME 108 0.0061
446 TACHYPNOEA 83 0.0061
447 AGRANULOCYTOSIS 113 0.0061
448 HAEMATURIA 208 0.0061
449 AUTOIMMUNE HEPATITIS 42 0.0060
450 POLYNEUROPATHY 72 0.0060
451 TORSADE DE POINTES 47 0.0060
452 FACE OEDEMA 101 0.0060
453 POST-TRAUMATIC STRESS DISORDER 40 0.0060
454 CHOLANGITIS 37 0.0060
455 RASH GENERALISED 154 0.0059
456 ACUTE CORONARY SYNDROME 49 0.0059
457 BLOOD URIC ACID INCREASED 34 0.0059
458 ACUTE PULMONARY OEDEMA 33 0.0059
459 ENCEPHALOPATHY 144 0.0059
460 MENINGITIS 39 0.0058
461 HYPERKALAEMIA 203 0.0058
462 PNEUMONIA BACTERIAL 53 0.0058
463 CLOSTRIDIUM DIFFICILE COLITIS 61 0.0057
464 CORONAVIRUS INFECTION 38 0.0057
465 HERPES VIRUS INFECTION 33 0.0057
466 HEPATOCELLULAR CARCINOMA 43 0.0056
467 LIVER INJURY 137 0.0056
468 DEVELOPMENTAL DELAY 50 0.0055
469 DRUG-INDUCED LIVER INJURY 173 0.0055
470 HEPATIC FUNCTION ABNORMAL 205 0.0055
471 NERVOUS SYSTEM DISORDER 170 0.0054
472 DISSEMINATED INTRAVASCULAR COAGULATION 76 0.0054
473 TOOTH EXTRACTION 67 0.0054
474 PROTHROMBIN TIME PROLONGED 32 0.0053
475 BLOOD CHOLESTEROL INCREASED 249 0.0053
476 COVID-19 PNEUMONIA 63 0.0053
477 GENERAL PHYSICAL CONDITION ABNORMAL 36 0.0053
478 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 41 0.0053
479 GASTROENTERITIS 77 0.0053
480 LYMPHOPENIA 74 0.0052
481 TREATMENT FAILURE 428 0.0052
482 RESPIRATORY DISTRESS 142 0.0051
483 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 132 0.0051
484 PURPURA 45 0.0051
485 DIALYSIS 72 0.0051
486 COAGULOPATHY 84 0.0050
487 HYPOALBUMINAEMIA 39 0.0050
488 SEROTONIN SYNDROME 96 0.0050
489 HYPERTHERMIA 38 0.0050
490 BONE MARROW FAILURE 101 0.0050
491 PERIPHERAL SENSORY NEUROPATHY 29 0.0050
492 DRUG SCREEN POSITIVE 39 0.0049
493 IMPAIRED WORK ABILITY 105 0.0049
494 MUSCLE ATROPHY 62 0.0049
495 HAEMATOTOXICITY 46 0.0048
496 HYPERGLYCAEMIA 176 0.0048
497 METABOLIC DISORDER 28 0.0048
498 SINUS TACHYCARDIA 68 0.0048
499 ARTERIOSCLEROSIS 45 0.0048
500 LYMPHOEDEMA 33 0.0048
501 ABNORMAL DREAMS 131 0.0047
502 BONE PAIN 275 0.0047
503 STATUS EPILEPTICUS 53 0.0047
504 ERECTILE DYSFUNCTION 119 0.0046
505 LEFT VENTRICULAR DYSFUNCTION 31 0.0046
506 CHROMATURIA 104 0.0046
507 HYPONATRAEMIA 257 0.0046
508 HYPERTHYROIDISM 66 0.0046
509 SUDDEN DEATH 48 0.0045
510 STEVENS-JOHNSON SYNDROME 100 0.0045
511 DUODENAL ULCER 31 0.0044
512 THROMBOCYTOPENIA 491 0.0044
513 ELECTROLYTE IMBALANCE 51 0.0044
514 PELVIC FRACTURE 34 0.0044
515 DIABETES MELLITUS 331 0.0043
516 GRAND MAL CONVULSION 40 0.0043
517 HAEMODYNAMIC INSTABILITY 33 0.0043
518 FEMUR FRACTURE 134 0.0043
519 BIPOLAR DISORDER 47 0.0043
520 LUNG INFILTRATION 38 0.0043
521 SUICIDAL IDEATION 393 0.0043
522 SQUAMOUS CELL CARCINOMA 40 0.0042
523 VENTRICULAR FIBRILLATION 47 0.0042
524 EYELID OEDEMA 49 0.0042
525 HEMIPLEGIA 35 0.0042
526 NEUROPATHY PERIPHERAL 400 0.0042
527 NEUTROPENIC SEPSIS 30 0.0042
528 DYSPHAGIA 397 0.0042
529 ERYTHEMA MULTIFORME 39 0.0042
530 LEUKOPENIA 209 0.0042
531 DRUG ERUPTION 74 0.0042
532 UVEITIS 56 0.0041
533 PULMONARY HYPERTENSION 86 0.0041
534 NEUROTOXICITY 72 0.0041
535 VITAMIN D DECREASED 35 0.0041
536 PSEUDOMONAS INFECTION 35 0.0041
537 PYREXIA 1412 0.0041
538 HEMIPARESIS 69 0.0041
539 MITRAL VALVE INCOMPETENCE 46 0.0041
540 BLOOD UREA INCREASED 68 0.0041
541 GENERAL PHYSICAL HEALTH DETERIORATION 467 0.0040
542 CHOLECYSTITIS 48 0.0040
543 TRICUSPID VALVE INCOMPETENCE 32 0.0040
544 CANDIDA INFECTION 68 0.0040
545 MALNUTRITION 45 0.0040
546 SEPTIC SHOCK 175 0.0040
547 IRON DEFICIENCY ANAEMIA 37 0.0040
548 PRESCRIBED OVERDOSE 77 0.0040
549 UTERINE LEIOMYOMA 29 0.0040
550 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
551 CORONARY ARTERY DISEASE 118 0.0039
552 GASTRIC ULCER 74 0.0039
553 CORONARY ARTERY OCCLUSION 53 0.0039
554 BRAIN OEDEMA 48 0.0038
555 POLLAKIURIA 158 0.0038
556 DIFFUSE LARGE B-CELL LYMPHOMA 29 0.0038
557 APPENDICITIS 35 0.0037
558 PARKINSONISM 36 0.0037
559 NIGHTMARE 126 0.0036
560 MYOCLONUS 43 0.0036
561 MYOCARDIAL ISCHAEMIA 41 0.0036
562 MULTIPLE ORGAN DYSFUNCTION SYNDROME 102 0.0036
563 MENTAL DISORDER 156 0.0036
564 MOBILITY DECREASED 257 0.0036
565 HYPOTHERMIA 36 0.0036
566 TOXIC EPIDERMAL NECROLYSIS 54 0.0036
567 GENERALISED OEDEMA 44 0.0036
568 ATAXIA 42 0.0035
569 DRUG DISPENSING ERROR 54 0.0035
570 EPILEPSY 108 0.0035
571 TUMOUR LYSIS SYNDROME 31 0.0035
572 GASTRITIS 92 0.0035
573 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 182 0.0035
574 GASTROINTESTINAL DISORDER 311 0.0035
575 VENTRICULAR EXTRASYSTOLES 36 0.0035
576 TOXICITY TO VARIOUS AGENTS 582 0.0034
577 SHOCK 79 0.0034
578 VOMITING 1614 0.0034
579 MENTAL STATUS CHANGES 95 0.0034
580 FLANK PAIN 32 0.0034
581 CONVULSION 195 0.0034
582 MYALGIA 577 0.0034
583 EMBOLISM 28 0.0034
584 COMA 160 0.0034
585 GASTROOESOPHAGEAL REFLUX DISEASE 270 0.0034
586 CIRCULATORY COLLAPSE 57 0.0033
587 GOUT 60 0.0033
588 FOLLICULITIS 35 0.0033
589 MOTOR DYSFUNCTION 34 0.0033
590 NEUTROPENIA 451 0.0033
591 INTERVERTEBRAL DISC PROTRUSION 72 0.0033
592 BRAIN INJURY 33 0.0033
593 CEREBRAL INFARCTION 80 0.0033
594 OEDEMA PERIPHERAL 395 0.0032
595 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
596 LUNG NEOPLASM MALIGNANT 132 0.0032
597 RESPIRATORY FAILURE 234 0.0032
598 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 55 0.0032
599 DERMATITIS ALLERGIC 40 0.0032
600 IMMUNOSUPPRESSION 28 0.0032
601 HIATUS HERNIA 41 0.0032
602 GAIT DISTURBANCE 603 0.0031
603 NOCTURIA 38 0.0031
604 CENTRAL NERVOUS SYSTEM LESION 43 0.0031
605 SINUS BRADYCARDIA 30 0.0031
606 DIARRHOEA 1996 0.0031
607 OPTIC NEURITIS 28 0.0031
608 DEPRESSED MOOD 162 0.0031
609 OEDEMA 166 0.0031
610 VERTIGO 186 0.0030
611 PRODUCT USE COMPLAINT 48 0.0030
612 CARDIOMYOPATHY 45 0.0030
613 ABDOMINAL PAIN 707 0.0030
614 BRADYCARDIA 161 0.0030
615 EUPHORIC MOOD 31 0.0030
616 SEPSIS 337 0.0030
617 BLOOD POTASSIUM INCREASED 49 0.0030
618 HYPOXIA 106 0.0030
619 EATING DISORDER 64 0.0030
620 WEIGHT INCREASED 673 0.0030
621 DIARRHOEA HAEMORRHAGIC 28 0.0030
622 PRODUCT DISPENSING ERROR 65 0.0030
623 MYOCARDITIS 34 0.0030
624 BLOOD IRON DECREASED 35 0.0029
625 LABORATORY TEST ABNORMAL 87 0.0029
626 COORDINATION ABNORMAL 41 0.0029
627 MYOCARDIAL INFARCTION 508 0.0029
628 C-REACTIVE PROTEIN INCREASED 105 0.0029
629 ASTHENIA 1081 0.0029
630 ABDOMINAL DISTENSION 300 0.0029
631 CARDIOMEGALY 35 0.0028
632 HYPERTENSION 601 0.0028
633 TOOTH DISORDER 63 0.0028
634 MUCOSAL INFLAMMATION 74 0.0028
635 WEIGHT DECREASED 788 0.0028
636 STAPHYLOCOCCAL INFECTION 93 0.0028
637 ORTHOSTATIC HYPOTENSION 49 0.0028
638 SUBDURAL HAEMATOMA 40 0.0028
639 NERVE INJURY 31 0.0028
640 SKIN LESION 76 0.0028
641 DEHYDRATION 369 0.0028
642 LEUKOCYTOSIS 50 0.0028
643 DYSURIA 101 0.0027
644 MANIA 45 0.0027
645 NIGHT SWEATS 88 0.0027
646 RASH PAPULAR 61 0.0027
647 HALLUCINATION, AUDITORY 43 0.0027
648 KIDNEY INFECTION 53 0.0027
649 PNEUMONIA 868 0.0027
650 DISORIENTATION 106 0.0027
651 SUICIDE ATTEMPT 162 0.0027
652 HAEMOGLOBIN DECREASED 273 0.0027
653 OESOPHAGITIS 29 0.0027
654 CEREBRAL HAEMORRHAGE 95 0.0027
655 SEXUAL DYSFUNCTION 31 0.0026
656 PNEUMONIA ASPIRATION 66 0.0026
657 NAUSEA 2084 0.0026
658 INTENTIONAL DOSE OMISSION 75 0.0026
659 THIRST 47 0.0026
660 VENTRICULAR TACHYCARDIA 43 0.0026
661 ACUTE RESPIRATORY FAILURE 50 0.0026
662 DIABETES MELLITUS INADEQUATE CONTROL 46 0.0026
663 HYPERCALCAEMIA 32 0.0026
664 PARALYSIS 37 0.0026
665 OBESITY 41 0.0026
666 BACTERIAL INFECTION 48 0.0026
667 TYPE 2 DIABETES MELLITUS 86 0.0026
668 IMMUNODEFICIENCY 38 0.0025
669 HYPOCALCAEMIA 48 0.0025
670 FEAR 68 0.0025
671 PNEUMOTHORAX 40 0.0025
672 SKIN ULCER 65 0.0025
673 PHARYNGITIS 31 0.0025
674 BLOOD CALCIUM DECREASED 28 0.0025
675 HYPOKINESIA 36 0.0025
676 SLEEP DISORDER 175 0.0025
677 DYSGEUSIA 183 0.0025
678 DEPRESSED LEVEL OF CONSCIOUSNESS 97 0.0024
679 NEOPLASM 28 0.0024
680 RASH 1061 0.0024
681 DERMATITIS 51 0.0024
682 NEURALGIA 59 0.0024
683 CONJUNCTIVITIS 45 0.0024
684 CARDIAC ARREST 200 0.0024
685 DYSARTHRIA 91 0.0024
686 INTENTIONAL PRODUCT USE ISSUE 211 0.0024
687 INSOMNIA 638 0.0024
688 BLOOD SODIUM DECREASED 45 0.0024
689 SCIATICA 38 0.0024
690 OSTEOMYELITIS 43 0.0024
691 CARPAL TUNNEL SYNDROME 33 0.0024
692 APHASIA 71 0.0023
693 JOINT INJURY 50 0.0023
694 HYPOTHYROIDISM 74 0.0023
695 PHOTOSENSITIVITY REACTION 38 0.0023
696 CARDIOGENIC SHOCK 33 0.0023
697 HERPES ZOSTER 132 0.0023
698 CARDIO-RESPIRATORY ARREST 96 0.0023
699 BACTERAEMIA 27 0.0023
700 DISTURBANCE IN ATTENTION 122 0.0023
701 BACK PAIN 523 0.0022
702 DELIRIUM 78 0.0022
703 DYSPNOEA EXERTIONAL 84 0.0022
704 SKIN DISORDER 74 0.0022
705 PRODUCT TASTE ABNORMAL 30 0.0022
706 HAEMATEMESIS 56 0.0022
707 ULCER 35 0.0022
708 GINGIVAL BLEEDING 30 0.0022
709 ARRHYTHMIA 104 0.0022
710 MEDICATION ERROR 122 0.0022
711 ABSCESS 35 0.0022
712 SENSORY DISTURBANCE 35 0.0022
713 ALTERED STATE OF CONSCIOUSNESS 47 0.0022
714 WHEEZING 128 0.0022
715 ANGIOEDEMA 95 0.0021
716 TENDONITIS 33 0.0021
717 BEDRIDDEN 28 0.0021
718 ANGINA PECTORIS 61 0.0021
719 IMMUNE SYSTEM DISORDER 28 0.0021
720 PULMONARY EMBOLISM 200 0.0021
721 RASH PRURITIC 114 0.0021
722 CYANOSIS 33 0.0021
723 LIVER FUNCTION TEST INCREASED 45 0.0021
724 SWELLING FACE 136 0.0021
725 HYPOMAGNESAEMIA 29 0.0021
726 HAEMORRHAGE INTRACRANIAL 31 0.0021
727 ANOSMIA 30 0.0021
728 CONDITION AGGRAVATED 629 0.0021
729 CONFUSIONAL STATE 333 0.0021
730 COGNITIVE DISORDER 96 0.0021
731 MUSCULAR WEAKNESS 233 0.0020
732 FEBRILE NEUTROPENIA 135 0.0020
733 PRURITUS GENERALISED 44 0.0020
734 TACHYCARDIA 180 0.0020
735 AMNESIA 131 0.0020
736 UNEVALUABLE EVENT 152 0.0020
737 BLOOD URINE PRESENT 38 0.0020
738 PULMONARY ARTERIAL HYPERTENSION 29 0.0020
739 INTERNATIONAL NORMALISED RATIO INCREASED 57 0.0020
740 ORAL HERPES 39 0.0020
741 ACCIDENTAL OVERDOSE 73 0.0020
742 BLOOD POTASSIUM DECREASED 60 0.0020
743 MOUTH ULCERATION 42 0.0020
744 VISUAL ACUITY REDUCED 66 0.0020
745 RESPIRATORY DISORDER 59 0.0020
746 FATIGUE 1530 0.0020
747 LUNG DISORDER 96 0.0020
748 MELAENA 43 0.0020
749 PALLOR 53 0.0019
750 DRUG INTOLERANCE 188 0.0019
751 PSYCHOMOTOR HYPERACTIVITY 32 0.0019
752 DRUG ADMINISTRATION ERROR 59 0.0019
753 APATHY 28 0.0019
754 HAEMATOCRIT DECREASED 38 0.0019
755 HAEMATOMA 49 0.0019
756 CHILLS 221 0.0019
757 INFLAMMATION 97 0.0019
758 ABNORMAL BEHAVIOUR 74 0.0019
759 ROAD TRAFFIC ACCIDENT 78 0.0019
760 ARTHRALGIA 775 0.0019
761 BODY TEMPERATURE INCREASED 38 0.0019
762 PERICARDIAL EFFUSION 43 0.0019
763 PLATELET COUNT DECREASED 198 0.0019
764 CARDIOVASCULAR DISORDER 47 0.0018
765 SYNCOPE 185 0.0018
766 CARDIAC FAILURE 148 0.0018
767 RESPIRATORY TRACT INFECTION 48 0.0018
768 GYNAECOMASTIA 57 0.0018
769 HYPOPHAGIA 47 0.0018
770 DEAFNESS 48 0.0018
771 DEEP VEIN THROMBOSIS 119 0.0018
772 MENTAL IMPAIRMENT 44 0.0018
773 CHEST PAIN 336 0.0018
774 MUSCULOSKELETAL DISCOMFORT 31 0.0018
775 FAECES DISCOLOURED 39 0.0018
776 HYPOGLYCAEMIA 87 0.0018
777 THERAPY CESSATION 92 0.0018
778 HYPERSENSITIVITY 332 0.0018
779 DECREASED APPETITE 414 0.0018
780 LOCAL SWELLING 31 0.0018
781 LETHARGY 102 0.0018
782 DYSPEPSIA 174 0.0018
783 OFF LABEL USE 1546 0.0018
784 ARTHRITIS 138 0.0018
785 EYE DISORDER 57 0.0017
786 PRODUCT DOSE OMISSION 113 0.0017
787 SLEEP APNOEA SYNDROME 33 0.0017
788 UPPER GASTROINTESTINAL HAEMORRHAGE 29 0.0017
789 SOMNOLENCE 346 0.0017
790 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
791 AGITATION 126 0.0017
792 PARAESTHESIA 266 0.0017
793 HYPOAESTHESIA 252 0.0017
794 MUSCULOSKELETAL DISORDER 32 0.0017
795 WHITE BLOOD CELL COUNT DECREASED 182 0.0017
796 TASTE DISORDER 34 0.0017
797 PANIC ATTACK 61 0.0017
798 ADVERSE EVENT 153 0.0017
799 RED BLOOD CELL COUNT DECREASED 47 0.0016
800 HAEMORRHOIDS 32 0.0016
801 HOSPITALISATION 251 0.0016
802 HYPOTENSION 327 0.0016
803 CEREBROVASCULAR ACCIDENT 276 0.0016
804 FLATULENCE 92 0.0016
805 GAIT INABILITY 54 0.0016
806 MOOD ALTERED 44 0.0016
807 COLITIS 61 0.0016
808 AGEUSIA 40 0.0016
809 ABDOMINAL PAIN UPPER 330 0.0016
810 GASTRIC DISORDER 55 0.0016
811 HEADACHE 1002 0.0016
812 INTERSTITIAL LUNG DISEASE 77 0.0016
813 RASH ERYTHEMATOUS 76 0.0016
814 OVERDOSE 340 0.0016
815 PRURITUS 605 0.0016
816 PRODUCT USE IN UNAPPROVED INDICATION 390 0.0016
817 PAIN IN EXTREMITY 463 0.0016
818 ISCHAEMIC STROKE 28 0.0016
819 GALLBLADDER DISORDER 28 0.0016
820 SEDATION 41 0.0016
821 SPEECH DISORDER 82 0.0016
822 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
823 PULMONARY OEDEMA 70 0.0016
824 PERITONITIS 32 0.0015
825 DISEASE RECURRENCE 73 0.0015
826 THROMBOSIS 123 0.0015
827 TINNITUS 70 0.0015
828 MALAISE 667 0.0015
829 RESTLESSNESS 55 0.0015
830 PLEURAL EFFUSION 91 0.0015
831 CONTRAINDICATED PRODUCT ADMINISTERED 45 0.0015
832 HALLUCINATION 112 0.0015
833 IRRITABILITY 89 0.0015
834 KNEE ARTHROPLASTY 31 0.0015
835 LOSS OF CONSCIOUSNESS 188 0.0015
836 DRUG ABUSE 122 0.0015
837 HYPERSOMNIA 42 0.0015
838 DEATH 1254 0.0015
839 CELLULITIS 73 0.0014
840 PRODUCTIVE COUGH 69 0.0014
841 DIZZINESS 719 0.0014
842 SKIN DISCOLOURATION 66 0.0014
843 SEIZURE 165 0.0014
844 PALPITATIONS 166 0.0014
845 ABASIA 35 0.0014
846 GASTROINTESTINAL HAEMORRHAGE 118 0.0014
847 BLOOD PRESSURE DECREASED 93 0.0014
848 PRESYNCOPE 34 0.0014
849 ANGER 47 0.0014
850 DYSPNOEA 786 0.0014
851 INTENTIONAL SELF-INJURY 28 0.0014
852 ADVERSE DRUG REACTION 123 0.0014
853 HAEMORRHAGE 143 0.0014
854 AGGRESSION 68 0.0014
855 NEUTROPHIL COUNT DECREASED 55 0.0013
856 ABDOMINAL PAIN LOWER 34 0.0013
857 IMPAIRED HEALING 44 0.0013
858 COVID-19 235 0.0013
859 BRONCHITIS 99 0.0013
860 INJURY 94 0.0013
861 BLINDNESS 54 0.0013
862 NEOPLASM MALIGNANT 88 0.0013
863 RASH MACULAR 46 0.0013
864 THERAPEUTIC RESPONSE UNEXPECTED 59 0.0013
865 DRUG DOSE OMISSION 217 0.0013
866 RESPIRATORY ARREST 36 0.0013
867 HYPERHIDROSIS 168 0.0013
868 CRYING 47 0.0013
869 VIRAL INFECTION 43 0.0013
870 URINARY RETENTION 43 0.0013
871 MEMORY IMPAIRMENT 176 0.0013
872 SKIN EXFOLIATION 108 0.0013
873 MOVEMENT DISORDER 41 0.0013
874 COUGH 355 0.0013
875 ATRIAL FIBRILLATION 123 0.0013
876 ABDOMINAL DISCOMFORT 210 0.0013
877 INFECTION 180 0.0012
878 HEART RATE IRREGULAR 28 0.0012
879 PRODUCT STORAGE ERROR 108 0.0012
880 RECTAL HAEMORRHAGE 53 0.0012
881 BLISTER 69 0.0012
882 THERAPY NON-RESPONDER 55 0.0012
883 MUSCULOSKELETAL PAIN 64 0.0012
884 DIABETIC KETOACIDOSIS 29 0.0012
885 DYSKINESIA 49 0.0012
886 LIP SWELLING 40 0.0012
887 UNRESPONSIVE TO STIMULI 31 0.0012
888 URTICARIA 201 0.0012
889 GLYCOSYLATED HAEMOGLOBIN INCREASED 30 0.0012
890 MUSCULOSKELETAL STIFFNESS 104 0.0012
891 WRONG TECHNIQUE IN DRUG USAGE PROCESS 43 0.0012
892 HAEMOPTYSIS 33 0.0012
893 URINARY TRACT INFECTION 199 0.0012
894 HEPATIC CANCER 28 0.0012
895 OXYGEN SATURATION DECREASED 65 0.0012
896 URINARY INCONTINENCE 34 0.0011
897 LOWER RESPIRATORY TRACT INFECTION 52 0.0011
898 LIMB INJURY 31 0.0011
899 INTENTIONAL OVERDOSE 73 0.0011
900 ARTHROPATHY 63 0.0011
901 NECK PAIN 63 0.0011
902 TREMOR 186 0.0011
903 CARDIAC DISORDER 104 0.0011
904 BALANCE DISORDER 96 0.0011
905 ILL-DEFINED DISORDER 67 0.0011
906 ERYTHEMA 226 0.0011
907 INFLUENZA LIKE ILLNESS 90 0.0011
908 CARDIAC FAILURE CONGESTIVE 87 0.0011
909 PRODUCT USE ISSUE 202 0.0011
910 OROPHARYNGEAL PAIN 99 0.0011
911 MOOD SWINGS 34 0.0011
912 STOMATITIS 64 0.0011
913 MUSCLE SPASMS 192 0.0010
914 BLOOD GLUCOSE INCREASED 197 0.0010
915 COMPLETED SUICIDE 87 0.0010
916 FEELING COLD 29 0.0010
917 VAGINAL HAEMORRHAGE 45 0.0010
918 HEAD INJURY 32 0.0010
919 NO ADVERSE EVENT 182 0.0010
920 DRY MOUTH 81 0.0010
921 FALL 332 0.0010
922 OCULAR HYPERAEMIA 47 0.0010
923 BURNING SENSATION 69 0.0010
924 FEELING HOT 60 0.0010
925 INJECTION SITE REACTION 67 0.0010
926 DISCOMFORT 59 0.0010
927 CHEST DISCOMFORT 99 0.0010
928 THERAPEUTIC RESPONSE DECREASED 58 0.0010
929 EMOTIONAL DISORDER 29 0.0009
930 FUNGAL INFECTION 31 0.0009
931 PERIPHERAL SWELLING 143 0.0009
932 INTENTIONAL PRODUCT MISUSE 81 0.0009
933 NASAL CONGESTION 54 0.0009
934 INFLUENZA 101 0.0009
935 ASTHMA 102 0.0009
936 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
937 VISION BLURRED 122 0.0009
938 ALOPECIA 174 0.0009
939 EPISTAXIS 66 0.0009
940 ECZEMA 46 0.0009
941 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
942 FEELING ABNORMAL 206 0.0009
943 SINUSITIS 88 0.0009
944 WITHDRAWAL SYNDROME 36 0.0009
945 VISUAL IMPAIRMENT 103 0.0008
946 ACNE 63 0.0008
947 MIGRAINE 78 0.0008
948 DRUG INEFFECTIVE 1076 0.0008
949 SWELLING 76 0.0008
950 CONSTIPATION 177 0.0008
951 FLUID RETENTION 41 0.0008
952 DYSPHONIA 47 0.0008
953 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 27 0.0008
954 HAEMATOCHEZIA 44 0.0008
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
956 SURGERY 45 0.0008
957 BLOOD PRESSURE INCREASED 113 0.0007
958 JOINT SWELLING 89 0.0007
959 THROAT IRRITATION 33 0.0007
960 RHINORRHOEA 47 0.0007
961 HEART RATE INCREASED 72 0.0007
962 CONTUSION 69 0.0007
963 NERVOUSNESS 37 0.0007
964 SKIN IRRITATION 32 0.0007
965 INCORRECT DOSE ADMINISTERED 155 0.0007
966 DRY SKIN 90 0.0007
967 EYE PAIN 38 0.0007
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
969 PROSTATE CANCER 52 0.0006
970 HOT FLUSH 48 0.0006
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 128 0.0006
972 NASOPHARYNGITIS 115 0.0006
973 RENAL CANCER 29 0.0006
974 PRODUCT DOSE OMISSION ISSUE 174 0.0006
975 PRODUCT SUBSTITUTION ISSUE 34 0.0006
976 CATARACT 35 0.0006
977 DRUG WITHDRAWAL SYNDROME 49 0.0006
978 DRUG EFFECT DECREASED 29 0.0005
979 DISEASE PROGRESSION 63 0.0005
980 ILLNESS 54 0.0005
981 EYE IRRITATION 30 0.0005
982 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 33 0.0005
983 FLUSHING 47 0.0005
984 SKIN BURNING SENSATION 32 0.0004
985 UNDERDOSE 29 0.0004
986 PRODUCT QUALITY ISSUE 53 0.0004
987 MALIGNANT NEOPLASM PROGRESSION 37 0.0004
988 DRUG DEPENDENCE 49 0.0003
989 PSORIASIS 38 0.0003
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
991 INJECTION SITE PAIN 60 0.0002